HOLX
HOLOGIC INC
Healthcare • CIK: 0000859737
Loading...
Market Cap
$16.74B
P/E (TTM)
30.8x
Rev Growth (TTM)
+2.2%
Net Margin (TTM)
13.2%
FCF Yield (TTM)
6.2%
FCF Margin (TTM)
25.2%
Cash Flow Health
Free Cash Flow8/8 positive
TTM$1.0B
Q '26
$215M-37%
Q4 '25
$341M+3%
FCF Margin
TTM25.2%
Q '2620.5%-37%
Sector: 5.8%Top 25%
OCF Margin26.6%
OCF/NI2.02x
CapEx Coverage19.4x
FCF Yield6.2%
FCF Growth (2Y)-15%
Cash Conversion Cycle
54 days
DSO: 54+DIO: –−DPO: –
Capital Allocation & Returns
Growth Focused
Total Shareholder YieldTTM
TTM1.4%
Div Yield0.0%
+Buyback (TTM)1.4%
Prioritizing reinvestment over distributions
Dividend & Payout Metrics
Dividend Yield (TTM)0.0%
Free Cash Flow (TTM)$1.0B
Stock Repurchases (TTM)$235.6M
Capital Return / FCF22.6%
Est. Dividends Paid (TTM)$0
Shows how management rewards shareholders
Operational Efficiency & Returns
Return on Invested CapitalTTM
10.9%
Stable
-0.2% YoY+0.5%
P25MedianP75
75th pctl (med: 0.1%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
14.3%
8Q: 18.4%
Asset Turnover
0.47x
8Q: 0.46x
Leverage (1+D/E)
1.48x
D/E: 0.48x
DuPont: 9.9% ≈ 10.9% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
7.37x
8Q:7.43x
-31.0%
Invested Cap Turn
0.76x
8Q:0.78x
Flat
CapEx Intensity
1.0%
8Q:1.1%
CapEx/Depreciation
0.19x
Depreciation Rate Trend
⚠ Declining -3.0%
Asset-based ROIC formula
QUARTERLY TRENDS
Last 8 quarters + TTM
| Metric | TTM | Q 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | $4.1B | $1.0B↓0.2% | $1.0B↑2.5% | $1.0B↑1.8% | $1.0B↓1.6% | $1.0B↑3.4% | $988.0M↓2.3% | $1.0B↓0.6% | $1.0B |
Operating Income | $721.5M | $237.0M↑0.0% | $236.9M↓7.0% | $254.6M↑3737.1% | $-7.0M↓103.0% | $229.8M↓0.1% | $230.0M↓5.7% | $244.0M↑16.0% | $210.4M |
Net Income | $543.8M | $179.1M↓4.3% | $187.2M↓4.0% | $194.9M↑1220.1% | $-17.4M↓108.7% | $201.0M↑12.5% | $178.6M↓8.2% | $194.5M↑14.5% | $169.9M |
Operating Cash Flow | $1.1B | $229.9M↓35.3% | $355.1M↑3.4% | $343.3M↑102.7% | $169.4M↓10.5% | $189.3M↓48.4% | $367.0M↓9.6% | $405.8M↑38.8% | $292.4M |
Free Cash Flow | $1.0B | $215.2M↓37.0% | $341.4M↑3.3% | $330.5M↑114.7% | $153.9M↓10.8% | $172.5M↓50.8% | $350.6M↓9.0% | $385.3M↑37.8% | $279.6M |
Total Equity | N/A |
Valuation Analysis
Fair Value
Price-to-EarningsTTM
30.8x
Valuation Lenses
Earnings
30.8x
vs – sector
Cash Flow
11803.3x
EV/FCF vs –
Growth-Adj
–PEG
N/A
Quality-Adj
2.8P/E per %ROIC
ROIC: 10.9%
Shareholder Returns
Dividend
–
Buyback
1.4%
Total Yield
1.4%
Market Cap$16.74B
EV–
Multi-angle valuation analysis with sector context
Business Quality & Moat
Overall Quality Score
76/100
High Quality
Composite score: Returns (40%) + Consistency (30%) + Earnings Quality (30%)
Returns on Capital
Return on Equity (ROE)Above Avg
11.1%
8Q:–
Return on Invested Capital (ROIC)Top 25%
10.9%
8Q:–
Flat
vs Sector:0.1%
DuPont Analysis (ROIC = NOPAT Margin × Asset Turnover)
NOPAT Margin: 14.3%
Asset Turnover: 0.47x
Earnings Quality
Cash Conversion
2.02x
OCF / Net Income ✓
FCF Consistency
–
Positive quarters
Competitive Moat Indicators
Pricing Power
Gross Margin51.5%
Capital Efficiency
Invested Capital Turnover0.76x
Working Capital
Cash Conversion Cycle54 days
Growth Quality & Momentum
Low Quality
Growth Quality Score
45/100
Growth 40%
Margins 30%
FCF 20%
Consistency 10%
Growth Rates
Revenue Growth YoY
2.2%
OpInc Growth YoY
3.1%
EPS Growth YoY
-24.1%
FCF 3Y CAGR
-15.0%
Growth Quality Analysis
⚠Working Capital Drag: FCF growth lagging revenue by 17.2%
⚠Sustainability Index: 3.0/10 - Growth sustainability concerns
Margin Quality & Sustainability
Low Quality
Profitability Cascade
Gross
51.5%
Operating
17.5%
Above Avg in sector
Net
13.2%
Margins Unknown
Earnings Quality Signals
SBC / Revenue
—
FCF vs Net Gap
+12.0 pts
FCF: 25.2% | Net: 13.2%
Quality = stability + cash conversion + low dilution
Balance Sheet & Solvency
Adequate
Net Debt / EBITDA
–Net Debt: $144.10M
Interest Coverage
–
Leverage Metrics
Debt-to-Equity
0.48x
Balance sheet risk & solvency analysis